EPIPEN 300 microgram (µg) Adrenaline Injection Syringe Auto-Injector (AUST R 42978)
Published 22 March 2017
Product
The following batches of EpiPen® 300 microgram (µg) Adrenaline Injection Syringe Auto-Injectors (AUST R 42978) used for the treatment of allergic emergencies (anaphylaxis)): Batch number 5FA665 Expiry Apr 17 Batch number 5FA6651 Expiry Apr 17 Batch number 5FA6652 Expiry Apr 17 Batch number 5FA6653 Expiry Apr 17
Why it was recalled
There is a potential that these devices may contain a defective part that may result in the device failing to activate or requiring increased force to activate.
Hazard
The failure of the auto-injector to activate may result in patients not receiving the required dose of adrenaline, causing the worsening of symptoms of anaphylaxis or anaphylactic reactions, which could be life threatening.
Source: Product Safety Australia. RecallMatch AU provides a screening summary and is independent of the ACCC.